Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States
Industries Focus
- Healthcare
- Digital Assets
- DeFi
- Emerging Technologies
- Web3
Investor Details Founded: 2021
Proxima VC is a venture capital firm specializing in healthcare investments, focusing on enterprises with highly innovative technologies. The firm operates across three disciplines: principal investments, advisory, and alternative investments. In principal investments, Proxima deploys proprietary capital at the inception and pre-seed stages, supporting founders with tokenomics, incentive design, technical and commercial talent, fundraising preparation, exchange listing support, and introductions to key ecosystem partners. Their advisory practice provides strategic and operational guidance across token architecture, governance, partner development, and capital strategy, working closely with founders to refine product and economic design, strengthen market positioning, and prepare for investor engagement. Additionally, Proxima evaluates select alternative investment opportunities that offer principal protection, low volatility, and stable return profiles, including structured yield solutions, credit-oriented strategies, and other risk-managed instruments designed to enhance capital resilience. This vertical ensures liquidity and stability, enabling consistent investment activity and strategic optionality across market cycles. The firm backs exceptional founders and ideas with clarity and conviction across Web3 infrastructure, DeFi, and emerging technologies. Founded in 2021 as Kronos Ventures, the venture arm of Kronos Research, Proxima rebranded in 2025 to expand its operations as an independent platform for ventures, liquid investments, and advisory. The team combines decades of experience across investment banking, private equity, venture capital, and digital assets, delivering disciplined investing backed by thorough diligence and deep operational expertise. The leadership team includes David Cai, Co-founder and Managing Partner; Jason Brannigan, Co-founder and General Partner; George Aranzaso, Co-founder and Research Partner; Bane Zhang, Advisor; Michael Dulski, Investment Analyst; and Evelyn Nguyen, Investment Analyst.
Requirements
- Focus on healthcare enterprises with innovative technologies
- Interest in Web3 infrastructure, DeFi, and emerging technologies
- Openness to early-stage investments including pre-seed and seed stages
- Alignment with Proxima's strategic and operational guidance in tokenomics and governance
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[Email Hidden]
Claim this Investor
Are you an official representative of Proxima VC?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim